TNDM Tandem Diabetes Care Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: TNDM

Price (delayed)

$14.07

Market cap

$964.2M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.39

Enterprise value

$1.52B

?
Relative Growth: Rel. Growth: 49
Relative Strength: Rel. Strength: 12
Relative Valuation: Rel. Valuation: 30
Relative Profitability: Rel. Profitability: 37

Tandem Diabetes Care is a public US medical device manufacturer based in San Diego, CA. The company develops medical technologies for the treatment of diabetes and specifically insulin infusion therapy. ...

Highlights
Tandem Diabetes Care's quick ratio has soared by 67% YoY and by 52% from the previous quarter
Tandem Diabetes Care's EPS has soared by 54% from the previous quarter and by 50% YoY
The debt has soared by 65% from the previous quarter and by 49% YoY
The company's equity fell by 15% YoY and by 15% QoQ
Sector: Healthcare
Industry: Medical Devices
Website: https://www.tandemdiabetes.com/
Peers: PODD ICUI DXCM DCTH

Key stats

What are the main financial stats of TNDM

TNDM stock price

How has the Tandem Diabetes Care stock price performed over time
Intraday
-1.88%
1 week
-15.7%
1 month
-5.98%
1 year
-30.42%
YTD
-35.99%
QTD
-26.6%

Financial performance

How have Tandem Diabetes Care's revenue and profit performed over time
Revenue
$1.03B
Gross profit
$564.4M
Operating income
-$83.81M
Net income
-$94.55M
Gross margin
54.9%
Net margin
-9.2%
The operating margin has soared by 56% from the previous quarter and by 55% YoY
The operating income has soared by 55% QoQ and by 53% YoY
The net margin has soared by 54% from the previous quarter and by 51% YoY
The net income has soared by 54% from the previous quarter and by 49% YoY

Price vs fundamentals

How does TNDM's price correlate with its fundamentals

Growth

What is Tandem Diabetes Care's growth rate over time

Valuation

What is Tandem Diabetes Care stock price valuation
P/E
N/A
P/B
7.26
P/S
0.94
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.48
Tandem Diabetes Care's EPS has soared by 54% from the previous quarter and by 50% YoY
TNDM's price to book (P/B) is 28% less than its 5-year quarterly average of 10.3 and 15% less than its last 4 quarters average of 8.7
The company's equity fell by 15% YoY and by 15% QoQ
The P/S is 78% lower than the 5-year quarterly average of 4.3 and 21% lower than the last 4 quarters average of 1.2
TNDM's revenue is up by 4.5% year-on-year

Efficiency

How efficient is Tandem Diabetes Care business performance
The return on invested capital has surged by 57% since the previous quarter and by 46% year-on-year
The return on assets has surged by 57% since the previous quarter and by 48% year-on-year
Tandem Diabetes Care's ROS has soared by 54% from the previous quarter and by 49% YoY
TNDM's ROE has soared by 52% from the previous quarter and by 17% YoY

Dividends

What is TNDM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TNDM.

Financial health

How did Tandem Diabetes Care financials performed over time
The total assets is 13% greater than the total liabilities
Tandem Diabetes Care's quick ratio has soared by 67% YoY and by 52% from the previous quarter
TNDM's current ratio has surged by 56% year-on-year and by 40% since the previous quarter
The company's debt to equity has surged by 94% QoQ and by 75% YoY
The debt has soared by 65% from the previous quarter and by 49% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.